Annual Report and Form 20-F Information

The report describes AstraZeneca's return to growth in 2019, with Total Revenue of $24,384 million and a year-end workforce of 70,600 employees. It highlights broad sustainability activity, including Scope 1, Scope 2 and Scope 3 emissions reporting, renewable-energy use, waste and water performance, and the Ambition Zero Carbon strategy. Sustainability disclosures were supported by a structured materiality assessment, GHG Protocol reporting and limited external assurance by Bureau Veritas.